Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Accelerated Access Review

- PMLiVE

Oxford PharmaGenesis wins King’s Award following rapid export growth

Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country.

Oxford PharmaGenesis

Rare Diseases on Medscape Education: Long-Chain Fatty Acid Oxidation Disorder

Rare Disease Day may be over but our committment to advancing outcomes for patients continues. Listen to a mother explain her daughter's journey with a long-chain fatty acid oxidation disorder.To...

Medscape Education Global

- PMLiVE

Impetus Digital’s Virtual Learning Programs named PM360’s Most Innovative Services of 2022

About the AwardToronto, ON, December 15, 2022 — PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Impetus Digital’s Virtual...

Impetus Digital

- PMLiVE

AstraZeneca’s Evusheld not recommended by NICE for COVID-19 prevention

The agency said there is not enough evidence of the drug’s effectiveness against current variants

You’re sitting on a time bomb, so think harder and give more!

A new philosophy for a new age?

Page & Page and Partners

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Enhertu recommended by NICE for advanced breast cancer

The treatment has been recommended for use within a managed access arrangement

- PMLiVE

Boehringer Ingelheim’s idiopathic pulmonary fibrosis treatment recommended by NICE

Patients will be eligible for the antifibrotic treatment earlier in the course of their disease

- PMLiVE

PMEA 2022: a celebration of excellence in healthcare marketing

Hosted by Mike Bushell, this year’s event was held at the Sheraton Grand London Park Lane

- PMLiVE

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

Medscape Education Global

- PMLiVE

Bristol Myers Squibb’s Opdivo recommended by NICE for rare gastroesophageal cancers

The PD-1 inhibitor demonstrated a statistically significant benefit in overall survival

How the Legally Blind Can Achieve Enhanced Vision

Roland Mattern, Director of Product Marketing at eSight Eyewear, shares how eSight’s technologies are being used to bring sight back to people living with central vision loss. He also discusses...

Impetus Digital

- PMLiVE

Porterhouse Medical US celebrates 5 years of working in harmony with our client partners

Globally acclaimed healthcare communications and medical insights network, Porterhouse Medical Group, is delighted to announce that our US-based team is celebrating its fifth anniversary this month. Porterhouse Medical US was...

Porterhouse Medical Group

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links